#United States #New York #Gross Law Firm #Revance Therapeutics #RVNC

Revance Therapeutics Class Action Lawsuit

On January 30, 2025, The Gross Law Firm announced a crucial notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). The firm urges all investors who purchased shares during the specified class period to take action before the imminent deadline of March 4, 2025, for lead plaintiff appointments. This class action arises from serious allegations regarding misrepresentations made by the company.

Key Dates and Deadlines

The class period for this lawsuit spans from February 29, 2024, to December 6, 2024. Investors who bought shares during this timeframe are encouraged to contact The Gross Law Firm for potential inclusion in the class action. Importantly, being appointed as a lead plaintiff is not a requirement for investors wishing to recover losses sustained from alleged corporate misconduct.

Allegations Against Revance

The complaint claims that Revance Therapeutics was involved in several misleading practices. Investors allege that the company:
1. Material Breach of Agreements: Revance reportedly breached the Distribution Agreement with Teoxane, which is critical for marketing dermal fillers.
2. Risk of Litigation: This breach allegedly increased Revance’s risk of litigation and potential monetary damages, along with reputational harm.
3. Delayed Tender Offer: The circumstances blocked a timely tender offer that investors were expecting, leading to further complications.
4. False Public Statements: It is suggested that Revance’s public declarations were materially false and misleading throughout the class period, prompting a lack of transparency about the company’s operational integrity.

Next Steps for Investors

Shareholders are strongly advised to register their information with The Gross Law Firm. Once registered, shareholders will have their statuses monitored throughout the litigation process. Moreover, they will receive updates regarding the case’s progress without any associated fees or obligations.

With the March 4, 2025 deadline approaching, investors should act swiftly to secure their place in the class action and potentially recover losses. Detailed registration can be done here.

Why Choose The Gross Law Firm?

The Gross Law Firm is a reputable class action litigation practice recognized across the nation. Their mission centers around defending investors' rights—especially those who have faced losses due to deceitful corporate behaviors and practices. The firm emphasizes its commitment to ensuring that companies uphold ethical standards in business and protect the interests of shareholders.

Investors looking to understand their rights or pursue legal remedies can reach out to The Gross Law Firm directly:

• - Address: 15 West 38th Street, 12th Floor, New York, NY 10018
• - Email: [email protected]
• - Phone: (646) 453-8903.

This announcement serves as an important reminder for all shareholders of Revance Therapeutics, Inc. to stay informed and engaged regarding their rights and options in light of the pending class action lawsuit.